Form 4: Envista Holdings Director Kieran Gallahue Receives Annual Equity Grant

Envista Holdings Corporation's Director, Kieran Gallahue, has reported the acquisition of 10,450 shares of common stock through an annual Restricted Stock Unit (RSU) grant.

Summary

• Kieran Gallahue, a Director at Envista Holdings Corp (NVST), acquired 10,450 shares of common stock on June 10, 2025.
• The acquisition was an annual equity grant of Restricted Stock Units (RSUs) for his service as a director.
• The RSUs were granted at a price of $0 per share, indicating a compensation grant.
• These RSUs will vest on the first anniversary of the grant date, converting to common stock on a one-to-one basis.
• Following this transaction, Kieran Gallahue beneficially owns 44,680 shares of Envista Holdings common stock.

Sentiment

Score: 7

Explanation: The sentiment is positive as the document reports a routine equity grant to a director, which aligns their interests with shareholders and is a standard compensation practice, indicating stability in governance and compensation structure.

Positives

• The equity grant aligns the director's financial interests with those of the shareholders, promoting long-term value creation.
• It represents a standard practice for compensating non-employee directors, ensuring continued engagement and commitment to the company's performance.

Future Outlook

The 10,450 Restricted Stock Units granted to Director Kieran Gallahue are scheduled to vest on the first anniversary of the grant date, which is June 10, 2026, at which point they will convert into shares of common stock.

Industry Context

The granting of Restricted Stock Units (RSUs) as part of director compensation is a common practice across various industries, including the healthcare and dental technology sectors where Envista Holdings operates. This method is widely used to incentivize long-term commitment and align the interests of directors with those of the company's shareholders.

Comparison to Industry Standards

• The use of equity grants, specifically Restricted Stock Units (RSUs), for director compensation is a standard and widely accepted practice across publicly traded companies, including those in the medical and dental device industry like Envista Holdings.
• This approach is consistent with corporate governance best practices aimed at aligning the interests of board members with long-term shareholder value creation, similar to companies such as Dentsply Sirona Inc. (XRAY) or Align Technology, Inc. (ALGN) which also utilize equity-based compensation for their directors.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with shareholders, potentially leading to better long-term decision-making and value creation.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The 10,450 Restricted Stock Units granted to Kieran Gallahue are expected to vest on June 10, 2026, converting into common stock.

Key Dates

Keywords

Envista Holdings, NVST, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, RSU, Equity Grant, Beneficial Ownership